世界のT細胞免疫療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5563 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、T細胞免疫療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CAR-T、TCR、TIL療法）、用途別市場規模（胃がん、肺がん、結腸直腸がん、食道がん、膵臓がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・T細胞免疫療法の市場動向 ・企業の競争状況、市場シェア ・T細胞免疫療法の種類別市場規模（CAR-T、TCR、TIL療法） ・T細胞免疫療法の用途別市場規模（胃がん、肺がん、結腸直腸がん、食道がん、膵臓がん、その他） ・T細胞免疫療法の北米市場規模2016-2027（アメリカ、カナダ） ・T細胞免疫療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・T細胞免疫療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・T細胞免疫療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・T細胞免疫療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Adaptimmune、Altor Bioscience Corporation、Cellectis、Juno Therapeutics、Kite Pharma、Novartis、Takara Bio、Unum Therapeutics） ・結論

Market Analysis and Insights: Global T-Cell Immunotherapy Market
The global T-Cell Immunotherapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global T-Cell Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global T-Cell Immunotherapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global T-Cell Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global T-Cell Immunotherapy market.

Global T-Cell Immunotherapy Scope and Market Size
T-Cell Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CAR-T
TCR
TIL Therapies

Segment by Application
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CAR-T
1.2.3 TCR
1.2.4 TIL Therapies
1.3 Market by Application
1.3.1 Global T-Cell Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophagus Cancer
1.3.6 Pancreatic Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global T-Cell Immunotherapy Market Perspective (2016-2027)
2.2 T-Cell Immunotherapy Growth Trends by Regions
2.2.1 T-Cell Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 T-Cell Immunotherapy Historic Market Share by Regions (2016-2021)
2.2.3 T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027)
2.3 T-Cell Immunotherapy Industry Dynamic
2.3.1 T-Cell Immunotherapy Market Trends
2.3.2 T-Cell Immunotherapy Market Drivers
2.3.3 T-Cell Immunotherapy Market Challenges
2.3.4 T-Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top T-Cell Immunotherapy Players by Revenue
3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2016-2021)
3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2016-2021)
3.2 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by T-Cell Immunotherapy Revenue
3.4 Global T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2020
3.5 T-Cell Immunotherapy Key Players Head office and Area Served
3.6 Key Players T-Cell Immunotherapy Product Solution and Service
3.7 Date of Enter into T-Cell Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Immunotherapy Breakdown Data by Type
4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2016-2021)
4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027)

5 T-Cell Immunotherapy Breakdown Data by Application
5.1 Global T-Cell Immunotherapy Historic Market Size by Application (2016-2021)
5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America T-Cell Immunotherapy Market Size (2016-2027)
6.2 North America T-Cell Immunotherapy Market Size by Type
6.2.1 North America T-Cell Immunotherapy Market Size by Type (2016-2021)
6.2.2 North America T-Cell Immunotherapy Market Size by Type (2022-2027)
6.2.3 North America T-Cell Immunotherapy Market Size by Type (2016-2027)
6.3 North America T-Cell Immunotherapy Market Size by Application
6.3.1 North America T-Cell Immunotherapy Market Size by Application (2016-2021)
6.3.2 North America T-Cell Immunotherapy Market Size by Application (2022-2027)
6.3.3 North America T-Cell Immunotherapy Market Size by Application (2016-2027)
6.4 North America T-Cell Immunotherapy Market Size by Country
6.4.1 North America T-Cell Immunotherapy Market Size by Country (2016-2021)
6.4.2 North America T-Cell Immunotherapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe T-Cell Immunotherapy Market Size (2016-2027)
7.2 Europe T-Cell Immunotherapy Market Size by Type
7.2.1 Europe T-Cell Immunotherapy Market Size by Type (2016-2021)
7.2.2 Europe T-Cell Immunotherapy Market Size by Type (2022-2027)
7.2.3 Europe T-Cell Immunotherapy Market Size by Type (2016-2027)
7.3 Europe T-Cell Immunotherapy Market Size by Application
7.3.1 Europe T-Cell Immunotherapy Market Size by Application (2016-2021)
7.3.2 Europe T-Cell Immunotherapy Market Size by Application (2022-2027)
7.3.3 Europe T-Cell Immunotherapy Market Size by Application (2016-2027)
7.4 Europe T-Cell Immunotherapy Market Size by Country
7.4.1 Europe T-Cell Immunotherapy Market Size by Country (2016-2021)
7.4.2 Europe T-Cell Immunotherapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific T-Cell Immunotherapy Market Size (2016-2027)
8.2 Asia-Pacific T-Cell Immunotherapy Market Size by Type
8.2.1 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2016-2027)
8.3 Asia-Pacific T-Cell Immunotherapy Market Size by Application
8.3.1 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2016-2027)
8.4 Asia-Pacific T-Cell Immunotherapy Market Size by Region
8.4.1 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America T-Cell Immunotherapy Market Size (2016-2027)
9.2 Latin America T-Cell Immunotherapy Market Size by Type
9.2.1 Latin America T-Cell Immunotherapy Market Size by Type (2016-2021)
9.2.2 Latin America T-Cell Immunotherapy Market Size by Type (2022-2027)
9.2.3 Latin America T-Cell Immunotherapy Market Size by Type (2016-2027)
9.3 Latin America T-Cell Immunotherapy Market Size by Application
9.3.1 Latin America T-Cell Immunotherapy Market Size by Application (2016-2021)
9.3.2 Latin America T-Cell Immunotherapy Market Size by Application (2022-2027)
9.3.3 Latin America T-Cell Immunotherapy Market Size by Application (2016-2027)
9.4 Latin America T-Cell Immunotherapy Market Size by Country
9.4.1 Latin America T-Cell Immunotherapy Market Size by Country (2016-2021)
9.4.2 Latin America T-Cell Immunotherapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa T-Cell Immunotherapy Market Size (2016-2027)
10.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type
10.2.1 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2016-2027)
10.3 Middle East & Africa T-Cell Immunotherapy Market Size by Application
10.3.1 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2016-2027)
10.4 Middle East & Africa T-Cell Immunotherapy Market Size by Country
10.4.1 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune T-Cell Immunotherapy Introduction
11.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2016-2021)
11.1.5 Adaptimmune Recent Development
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Details
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
11.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2016-2021)
11.2.5 Altor Bioscience Corporation Recent Development
11.3 Cellectis
11.3.1 Cellectis Company Details
11.3.2 Cellectis Business Overview
11.3.3 Cellectis T-Cell Immunotherapy Introduction
11.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2016-2021)
11.3.5 Cellectis Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
11.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2016-2021)
11.4.5 Juno Therapeutics Recent Development
11.5 Kite Pharma
11.5.1 Kite Pharma Company Details
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma T-Cell Immunotherapy Introduction
11.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2016-2021)
11.5.5 Kite Pharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis T-Cell Immunotherapy Introduction
11.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio T-Cell Immunotherapy Introduction
11.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2016-2021)
11.7.5 Takara Bio Recent Development
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Details
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
11.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2016-2021)
11.8.5 Unum Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR
Table 4. Key Players of TIL Therapies
Table 5. Global T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global T-Cell Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global T-Cell Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global T-Cell Immunotherapy Market Share by Regions (2016-2021)
Table 9. Global T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global T-Cell Immunotherapy Market Share by Regions (2022-2027)
Table 11. T-Cell Immunotherapy Market Trends
Table 12. T-Cell Immunotherapy Market Drivers
Table 13. T-Cell Immunotherapy Market Challenges
Table 14. T-Cell Immunotherapy Market Restraints
Table 15. Global T-Cell Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global T-Cell Immunotherapy Market Share by Players (2016-2021)
Table 17. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Immunotherapy as of 2020)
Table 18. Ranking of Global Top T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by T-Cell Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players T-Cell Immunotherapy Product Solution and Service
Table 22. Date of Enter into T-Cell Immunotherapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
Table 26. Global T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global T-Cell Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global T-Cell Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)
Table 30. Global T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global T-Cell Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Adaptimmune Company Details
Table 63. Adaptimmune Business Overview
Table 64. Adaptimmune T-Cell Immunotherapy Product
Table 65. Adaptimmune Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 66. Adaptimmune Recent Development
Table 67. Altor Bioscience Corporation Company Details
Table 68. Altor Bioscience Corporation Business Overview
Table 69. Altor Bioscience Corporation T-Cell Immunotherapy Product
Table 70. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 71. Altor Bioscience Corporation Recent Development
Table 72. Cellectis Company Details
Table 73. Cellectis Business Overview
Table 74. Cellectis T-Cell Immunotherapy Product
Table 75. Cellectis Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 76. Cellectis Recent Development
Table 77. Juno Therapeutics Company Details
Table 78. Juno Therapeutics Business Overview
Table 79. Juno Therapeutics T-Cell Immunotherapy Product
Table 80. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 81. Juno Therapeutics Recent Development
Table 82. Kite Pharma Company Details
Table 83. Kite Pharma Business Overview
Table 84. Kite Pharma T-Cell Immunotherapy Product
Table 85. Kite Pharma Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 86. Kite Pharma Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis T-Cell Immunotherapy Product
Table 90. Novartis Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Takara Bio Company Details
Table 93. Takara Bio Business Overview
Table 94. Takara Bio T-Cell Immunotherapy Product
Table 95. Takara Bio Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 96. Takara Bio Recent Development
Table 97. Unum Therapeutics Company Details
Table 98. Unum Therapeutics Business Overview
Table 99. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 100. Unum Therapeutics Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-Cell Immunotherapy Market Share by Type: 2020 VS 2027
Figure 2. CAR-T Features
Figure 3. TCR Features
Figure 4. TIL Therapies Features
Figure 5. Global T-Cell Immunotherapy Market Share by Application: 2020 VS 2027
Figure 6. Stomach Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Esophagus Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. T-Cell Immunotherapy Report Years Considered
Figure 13. Global T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global T-Cell Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global T-Cell Immunotherapy Market Share by Regions: 2020 VS 2027
Figure 16. Global T-Cell Immunotherapy Market Share by Regions (2022-2027)
Figure 17. Global T-Cell Immunotherapy Market Share by Players in 2020
Figure 18. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Immunotherapy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2020
Figure 20. Global T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
Figure 21. Global T-Cell Immunotherapy Revenue Market Share by Type (2022-2027)
Figure 22. North America T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 24. North America T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 25. North America T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 26. United States T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 30. Europe T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 31. Europe T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 32. Germany T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific T-Cell Immunotherapy Market Share by Region (2016-2027)
Figure 42. China T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 50. Latin America T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 51. Latin America T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 52. Mexico T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 58. Turkey T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 62. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 63. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 64. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 65. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 67. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 68. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---